Accredo
HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Hurler Scheie (MPS I) - overview

Hurler Scheie (MPS I) - overview

Overview | FAQs | Lysosomal storage disorders

Mucopolysaccharidosis I (MPS I) is a progressive, debilitating, and often life-threatening disease. It is an inherited disorder caused by a deficiency of alpha-L-iduronidase. This enzyme is required for the breakdown of bodily substances known as glycosaminoglycans (GAG). As GAG builds up in a person’s body, almost any organ can be damaged. Therefore, early diagnosis and treatment are important. MPS I is also known as Hurler syndrome, Hurler-Scheie syndrome, and Scheie syndrome.

Standard treatment is with Aldurazyme®.


Aldurazyme is a registered trademark of Genzyme Corporation.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us